Press Releases
Portland Timbers Enter Multi-Year Community Impact Partnership with Bank of America
BofA Becomes Front of Jersey Partner, Tillamook to Remain on Kit With Sleeve Patch PORTLAND, Ore., Dec. 9, 2025 /PRNewswire/ -- The Portland Timbers t...
By SquaredTown on December 9, 2025
Yahoo Sports Network Adds Live Indoor Football League Games to Growing Programming Slate
The new Yahoo Sports streaming TV channel will be the exclusive home for 59 IFL games in 2026. SIOUX FALLS, S.D., Dec. 9, 2025 /PRNewswire/ -- Yahoo S...
By SquaredTown on December 9, 2025
TruGolf Links Franchisee Takes on Developing all of Long Island
Successful Healthcare Entrepreneur Goes All in to Develop Long Island Iconic Golf Simulator Company's New Concept CENTERVILLE, Utah, Dec. 9, 2025 /PRN...
By SquaredTown on December 9, 2025
The LandTek Group and The Marty Lyons Foundation Grant Rayan's Wish with Help from Hellas.
BAY SHORE, N.Y., Dec. 9, 2025 /PRNewswire/ -- The LandTek Group, a leader in sports facility construction and member of the TenCate family of companie...
By SquaredTown on December 9, 2025
CCM Hockey Announces Multi-Year Partnership with the Montreal Canadiens Children's Foundation and the Montreal Canadiens' organization
MONTREAL, Dec. 9, 2025 /PRNewswire/ - CCM Hockey announces a multi-year partnership with the Montreal Canadiens organization and the Montreal Canadien...
By SquaredTown on December 9, 2025
For One Night Only, Michelob ULTRA Is Running It Back To 1980 With An Immersive Reimagining of the 'Miracle on Ice' Game
Official Beer Sponsor of Team USA, Michelob ULTRA, is rolling out the red, white and blue carpet with a full-scale national campaign anchored by uniqu...
By SquaredTown on December 9, 2025
Travis Pastrana goes max attack in the land down under in Gymkhana 2025: Aussie Shred
All-new 670-horsepower active-aero-equipped Subaru "Brataroo" makes its film debut in the boldest installment of the iconic Gymkhana film series yet C...
By SquaredTown on December 9, 2025
Purina Announces Donations to Five Leading Veterinary Schools to Foster Advancements in Veterinary Care
Programs at The University of Pennsylvania, Auburn University, University of Florida, Colorado State University, and Cornell University aim to build d...
By SquaredTown on December 9, 2025
La Escuela de Negocios Stern de la Universidad de Nueva York en Abu Dabi publica su primer FCCI
- La Escuela de Negocios Stern de la Universidad de Nueva York en Abu Dabi publica su primer Índice de Competitividad del Centro Financiero Los resul...
By SquaredTown on December 9, 2025
Spectral Capital Announces Projected $450,000,000 in Projected 2026 Revenue in Connection with NASDAQ Uplisting; Engages Revere Securities
SEATTLE, Dec. 9, 2025 /PRNewswire/ -- Spectral Capital Corporation (OTCQB: FCCN) ("Spectral" or the "Company") today announced 2026 revenue guidance o...
By SquaredTown on December 9, 2025
US Air Force Awards ThroughPut.ai Phase III Contract for "Aircraft Availability Optimization"
PALO ALTO, Calif., Dec. 9, 2025 /PRNewswire/ -- Industrial AI pioneer ThroughPut.AI announces it has been awarded its second SBIR Phase III contract f...
By SquaredTown on December 9, 2025
From Research to Measurable Patient Outcomes, Bio-IT World Conference & Expo Celebrates 25th Annual Event Advancing the Future of Precision Medicine
Premier Global Gathering of Biopharma, Healthcare and IT Leaders Set for May 19-21, 2026 in Boston, With "Super Early Bird" Rates Available Until Dece...
By SquaredTown on December 9, 2025
Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market
SACRAMENTO, Calif., Dec. 9, 2025 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered biotechnology company developing precision therapeutics,...
By SquaredTown on December 9, 2025
Ajust Design Adds Strategic Communication Practice as Private Equity Firms Encounter Growing Competition for Capital
New practice integrates brand strategy with design execution for private capital firms CHICAGO, Dec. 9, 2025 /PRNewswire/ -- Ajust Design today announ...
By SquaredTown on December 9, 2025
Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma
TECVAYLI® and DARZALEX FASPRO® combination led to a statistically significant progression-free survival and overall survival advantage compared to s...
By SquaredTown on December 9, 2025
Elanco Investor Day Defines New Era as Sustainable Growth Company
Details three-year outlook with annual mid-single digit top-line organic constant currency growth driven by a consistent flow of high-impact innovatio...
By SquaredTown on December 9, 2025
From a Simple Idea to a Global Standard: EV Blocks Founder Wins Global Entrepreneur of the Year 2025
What started as a frustration on site has become a global product. PETERBOROUGH, England, Dec. 9, 2025 /PRNewswire/ -- EV Blocks is proud to share tha...
By SquaredTown on December 9, 2025
Pariveda Awarded a 2025 AWS Partner Award
Pariveda recognized as Social Impact Partner of the Year winner, one of many AWS Partners around the globe that help their customers drive innovation ...
By SquaredTown on December 9, 2025
Pariveda Named a 2025 Geo and Global AWS Partner Award Finalist
Pariveda recognized as Application Modernization SI Partner of the Year finalist, one of many AWS Partners around the globe that help their customers ...
By SquaredTown on December 9, 2025
Recordati Rare Diseases Announces Real-World Data on Long-Term Safety of ENJAYMO® (sutimlimab-jome) in Cold Agglutinin Disease and Cold Agglutinin Syndrome (CAD/CAS) at American Society of Hematology (ASH) Annual Meeting
Results from CADENCE, the first and largest multinational prospective registry for patients with CAD/CAS, describe safety events observed in patients ...
By SquaredTown on December 9, 2025
Novel Agent Ianalumab Added to Standard Therapy Extends Time to Treatment Failure in Patients with Previously Treated Immune Thrombocytopenia
LBA-2: Primary results from VAYHIT2, a randomized, double-blind, phase 3 trial of ianalumab plus eltrombopag versus placebo plus eltrombopag in patien...
By SquaredTown on December 9, 2025
Drug Reduced Need for Blood Transfusions During Hospitalization for Non-Cardiac Surgery
LBA-5: A hospital policy of tranexamic acid to reduce transfusion in major non-cardiac surgery: The TRACTION trial ORLANDO, Fla., Dec. 9, 2025 /PRNews...
By SquaredTown on December 9, 2025
Bed Bath & Beyond Appoints Nora Gomez as Chief Merchandising Officer
Strategic hire strengthens focus on growth, margin expansion, and whole-home execution entering 2026 MURRAY, Utah and NASHVILLE, Tenn., Dec. 9, 2025 /...
By SquaredTown on December 9, 2025
Tec-Dara Combination Offers Substantial Improvement Over Standard Second-Line Therapies for Relapsed or Refractory Multiple Myeloma
LBA-6: Phase 3 randomized study of teclistamab plus daratumumab versus investigator's choice of daratumumab and dexamethasone with either pomalidomide...
By SquaredTown on December 9, 2025
Pirtobrutinib Outperforms Bendamustine Plus Rituximab for Previously Untreated CLL/SLL
LBA-3: Pirtobrutinib vs Bendamustine Plus Rituximab (BR) in Patients with CLL/SLL: First Results from a Randomized Phase III Study Examining a Non-Cov...
By SquaredTown on December 9, 2025